Nuclear Medicine Journal Previews April 2026 Issue

New studies explore advanced imaging and treatment approaches for kidney, liver, prostate, and lung cancers.

Apr. 18, 2026 at 1:42am

Got story updates? Submit your updates here. ›

A highly structured abstract painting in soft, muted tones featuring sweeping geometric arcs, concentric circular forms, and precise botanical spirals, conceptually representing the interconnected advancements in nuclear medicine and molecular imaging technologies.Innovative nuclear medicine techniques are enabling more precise, personalized, and effective approaches to cancer diagnosis and treatment.Reston Today

The Journal of Nuclear Medicine has published several new research articles ahead of its April 2026 issue, covering a range of innovative diagnostic and therapeutic techniques in nuclear medicine. The studies explore the use of novel PET tracers and radiopharmaceuticals to improve cancer detection, treatment monitoring, and patient outcomes across multiple tumor types.

Why it matters

These studies highlight the rapid advancements being made in nuclear medicine and molecular imaging, which are enabling more precise, personalized, and effective approaches to cancer care. The findings could lead to improved diagnosis, staging, and management of challenging cancers, ultimately benefiting patients.

The details

The new research includes studies on: using a dual-purpose imaging and treatment tracer for kidney cancer; comparing PET/CT scans with different tracers to better evaluate liver lesions; detecting recurrent prostate cancer with a second PSMA PET/CT scan; monitoring advanced prostate cancer treatment response with a circulating tumor DNA blood test; visualizing the immune response during lung cancer immunotherapy; and leveraging total-body dynamic PET to rapidly image parathyroid disease. Additionally, a study found that adding PSMA PET to standard imaging can improve disease staging and prognosis prediction in metastatic hormone-sensitive prostate cancer.

  • The new research articles were published ahead-of-print by The Journal of Nuclear Medicine on April 17, 2026.

The players

The Journal of Nuclear Medicine (JNM)

JNM is the official journal of the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics.

Society of Nuclear Medicine and Molecular Imaging

An international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

Got photos? Submit your photos here. ›

The takeaway

These studies demonstrate the rapid progress being made in nuclear medicine and molecular imaging, which are enabling more precise, personalized, and effective approaches to cancer diagnosis, staging, and treatment. The findings could lead to significant improvements in patient outcomes across a range of challenging tumor types.